ESC Professional Premium Access

Pembrolizumab, Ipilimumab and Nivolumab reduces cardiac pAMPK and IL-10, increases vascular NF-kB expression and levels of IL-1b, IL-2 and IL-6 in myocardial tissue

Congress Presentation

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
2 presentations
1 follower

6 more presentations in this session

Berberine associated to SGLT2i Dapagliflozin synergistically reduces cardiac cell apoptosis during exposure to Trastuzumab through reduction of AGEs and IL-6 and induction of pAMPK

Speaker: Doctor N. Maurea (Naples, IT)

Thumbnail

Dose-dependency of diclofenac's cardiovascular risks: a series of nationwide emulated trials

Speaker: Associate Professor M. Schmidt (Aarhus, DK)

Thumbnail

Cardiovascular risk following cannabinoid treatment for patients with chronic pain

Speaker: Mrs N. Nouhravesh (Gentofte, DK)

Thumbnail

Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient

Speaker: Mr E. Fort (Barcelona, ES)

Thumbnail

Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction

Speaker: Doctor N. Maurea (Naples, IT)

Thumbnail

Access the full session

Drug cardiotoxicity: what do we need to know?

Speakers: Doctor N. Maurea, Doctor N. Maurea, Associate Professor M. Schmidt, Mrs N. Nouhravesh, Mr E. Fort...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk